Harvest One Cannabis Inc. - Favourable Results from Phase 2 Clinical Trials using Satipharm Capsules
VANCOUVER, Feb. 1, 2018 /CNW/ - Harvest One Cannabis Inc. (TSXV:HVT; HVST) ("Harvest One" or the "Company") through its wholly-owned subsidiary Satipharm AG ("Satipharm") is pleased to announce its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback